Sign inJoin waitlistJoin the waitlist

Sairah Ahmed

Director of CART Program, Lymphoma/Myeloma · University of Texas M D Anderson Cancer Center

Credentials: · · · · · · · ·

History

University of Texas M D Anderson Cancer Center
Present
University of Texas M D Anderson Cancer Center
Present

University of Texas M D Anderson Cancer Center
2011–2012
Northwestern University
2009–2010
Internal Medicine
University of Connecticut School of Medicine
2003–2006
Khyber Teaching Hospital
2001–2002
Doctor of Medicine
1996–2000

Research

Gene silencing in cancer by histone H3 lysine 27 trimethylation independent of promoter DNA methylation
Nature Genetics · 2008 · 492 citations
Integrated genetic and epigenetic analysis identifies three different subclasses of colon cancer
Proceedings of the National Academy of Sciences of the United States of America · 2007 · 423 citations
Immune Effector Cell-Associated Hemophagocytic Lymphohistiocytosis-Like Syndrome
Transplantation and Cellular Therapy · 2023 · 331 citations

Elizabeth Shpall
81 papers
Richard Champlin
69 papers
Sattva Neelapu
63 papers
Partow Kebriaei
61 papers
Jason Westin
59 papers
Loretta Nastoupil
59 papers · 3 as a fellow
Yago Nieto
59 papers
Uday Popat
55 papers
Chitra Hosing
54 papers
Paolo Strati
53 papers
Christopher Flowers
52 papers
Amin Alousi
46 papers

Clinical trials

Autologous CD30.CAR-T in Combination With Nivolumab in cHL Patients After Failure of Frontline Therapy
Principal investigator · Active not recruiting · Phase 1
Tessa Therapeutics
2022–2037
Phase 1 Study of Autologous CD30.CAR-T in Relapsed or Refractory CD30 Positive Non-Hodgkin Lymphoma
Principal investigator · Active not recruiting · Phase 1
Tessa Therapeutics
2021–2036
Brentuximab Vedotin in High-Risk CD30+ Lymphoma Post Allogeneic Stem Cell Transplantation (AlloSCT)
Principal investigator · Terminated · Phase 2
M.D. Anderson Cancer Center
2015–2017
Donor Cord Blood T-Cell Infusion After Stem Cell Transplant in Treating Patients With Relapsed Hematological Malignancies
Principal investigator · Terminated · Phase 1
M.D. Anderson Cancer Center
2013–2018